UK NICE · July 16, 2026

NICE recommendation: finerenone for chronic heart failure with preserved or mildly reduced ejection fraction

Original title: Thousands eligible for new chronic heart failure treatment following NICE recommendation

NICE recommends finerenone for adults with chronic heart failure with preserved or mildly reduced ejection fraction in England.

Low obligation Product class Pharmaceuticals Market Access & Reimbursement UK Reimbursement

People in England with a type of chronic heart failure could benefit from a new treatment option. Our final draft guidance recommends finerenone for adults with chronic heart failure with preserved or mildly reduced ejection fraction.

Read the official source ↗

Published by UK NICE. HealthSignal links to the original document; the summary above is extracted from the source text.